Evidence map›Paper›PMID 24391687›Full record

ArticlePloS one2013

Disability transitions after 30 months in three community-dwelling diagnostic groups in Spain.

Jesús de Pedro-Cuesta, Pilar García-Sagredo, Enrique Alcalde-Cabero, Angel Alberquilla, Javier Damián, Graciela Bosca, Fernando López-Rodríguez, Montserrat Carmona, Monserrat Carmona, María J de Tena-Dávila and 2 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. WHODAS 2.0 to Assess Disability in the Rehabilitation of Individuals With Chronic Respiratory Conditions: Responsiveness and Interpretability.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2026
    Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

  • Erratum issued
    Carmona, Monserrat [corrected to Carmona, Montserrat]
5 · Who and what money

Authors and funding

12 authors.

Jesús de Pedro-CuestaApplied Epidemiology, National Centre for Epidemiology and Carlos III Institute of Health, Madrid, Spain.
Pilar García-SagredoTelemedicine and Health Unit, Carlos III Institute of Health, Madrid, Spain.
Enrique Alcalde-CaberoApplied Epidemiology, National Centre for Epidemiology and Carlos III Institute of Health, Madrid, Spain.
Angel AlberquillaMultiprofessional Education Unit for Family and Community Care (Centre), Servicio Madrileño de Salud, Madrid, Spain.
Javier DamiánApplied Epidemiology, National Centre for Epidemiology and Carlos III Institute of Health, Madrid, Spain.
Graciela BoscaTelemedicine and Health Unit, Carlos III Institute of Health, Madrid, Spain.
Fernando López-RodríguezTelemedicine and Health Unit, Carlos III Institute of Health, Madrid, Spain.
Montserrat Carmona
Monserrat CarmonaBioengineering and Telemedicine Unit, Puerta de Hierro University Teaching Hospital, Madrid, Spain.
María J de Tena-DávilaTelemedicine and Health Unit, Carlos III Institute of Health, Madrid, Spain.
Luis García-OlmosMultiprofessional Education Unit for Family and Community Care (South-east), Servicio Madrileño de Salud, Madrid, Spain.
Carlos H SalvadorTelemedicine and Health Unit, Carlos III Institute of Health, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known about changes in disability over time among community-dwelling patients. Accordingly, this study sought to assess medium-term disability transitions. PATIENTS AND

methods300 chronic obstructive pulmonary disease (COPD), chronic heart failure and stroke patients living at home in Madrid were selected from general practitioner lists. In 2009, disability was assessed after a mean of 30 months using the World Health Organisation (WHO) Disability Assessment Schedule 2.0 (WHODAS 2.0). Follow-up was completed using death registries. Losses to follow-up were due to: death, 56; institutionalisation, 9; non-location, 18; and non-participation, 17. Changes in WHODAS 2.0 scores and life status were described and analysed using Cox and multinomial regression. Disability at end of follow-up was imputed for 56 deceased and 44 surviving patients.

resultsMean disability scores for 200 surviving patients at end of follow-up were similar to baseline scores for the whole group, higher than their own baseline scores, and rose by 16.3% when imputed values were added. The strongest Cox predictors of death were: age over 84 years, adjusted hazard ratios with 95%CI 8.18 (3.06-21.85); severe/complete vs. no/mild disability, 5.18 (0.68-39.48); and stroke compared to COPD, 1.40 (0.67-2.91). Non-participants and institutionalised patients had higher proportions with severe/complete baseline disability. A one-point change in baseline WHODAS 2.0 score predicted independent increases in risk of 12% (8%-15%) for severe/complete disability or death.

conclusionsA considerably high proportion of community-dwelling patients diagnosed with COPD, CHF and stroke undergo medium-term changes in disability or vital status. The main features of the emerging pattern for this group appear to be as follows: approximately two-thirds of patients continue living at home with moderately reduced functional status; 1/3 die or worsen to severe/complete disability; and 1/10 improve. Baseline disability scores, age and diagnosis are associated with disability and death in the medium term.

Indexed as

Disability EvaluationActivities of Daily LivingAgedAge FactorsChronic DiseaseFemaleFollow-Up StudiesHeart FailureHumansLung Diseases, ObstructiveMaleMiddle AgedPulmonary Disease, Chronic ObstructiveResidence CharacteristicsSpainStroke

Identifiers

PMID24391687
PMCPMC3879317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.